Sonnet BioTherapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Investments - Summary of Sale Securities Available (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Schedule of Available-for-sale Securities [Line Items]
Cost	$ 35,362us-gaap_AvailableForSaleSecurities	$ 55,112us-gaap_AvailableForSaleSecurities
Unrecongnized Holding Gains (Losses)	(227,969)	(208,219)
Fair Value	35,362us-gaap_InvestmentsFairValueDisclosure	55,112us-gaap_InvestmentsFairValueDisclosure
Realized Holding Loss		0
Gain on Sale	46,292	0
Appalachian Mountain Brewery [Member]
Schedule of Available-for-sale Securities [Line Items]
Cost	1,500	1,500
Unrecongnized Holding Gains (Losses)	23,300	(118,169)
Fair Value	24,800	44,550
Realized Holding Loss		0
Gain on Sale	46,292	0
North American Energy One [Member]
Schedule of Available-for-sale Securities [Line Items]
Cost	126,000	126,000
Unrecongnized Holding Gains (Losses)	(123,200)	43,050
Fair Value	2,800	2,800
Realized Holding Loss		0
Gain on Sale		0
North American Energy Two [Member]
Schedule of Available-for-sale Securities [Line Items]
Cost	10,500	10,500
Unrecongnized Holding Gains (Losses)	(9,900)	(123,200)
Fair Value	600	600
Realized Holding Loss		0
Gain on Sale		0
North American Energy Three [Member]
Schedule of Available-for-sale Securities [Line Items]
Cost	125,331	125,331
Unrecongnized Holding Gains (Losses)	(118,169)	(9,900)
Fair Value	7,162	7,162
Realized Holding Loss		0
Gain on Sale		0
Available-for-Sale Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Cost	263,331	263,331
Fair Value	$ 35,362	$ 55,112